Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Immunol Res ; 69(1): 90-99, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33515426

RESUMO

The persistence of residual infection is one of the major factors in failure of the Global Programme to Eliminate Lymphatic Filariasis (GPELF). The present study aims to explore the status of sheath antibody and regulatory T cells (Tregs) known to play key roles in clearance of parasite and patent filarial infection, in individuals with residual infection after MDA. A total of 61 microfilaremic (Mf) individuals were followed up after at least 6 rounds of MDA. Infection status of subjects was assessed through the detection of Mf and circulating filarial antigen (CFA). Antibodies to Mf sheath were determined by immuno-peroxidase assay (IPA). The expression of Tregs was measured by a flow cytometer. IL-10 and IFN-γ were evaluated using the commercially available ELISA kit. The sheath antibody was present in subjects who have cleared both Mf and CFA and absent in individuals who were found to be Mf /CFA positive. Further individuals carrying infection have significantly high levels of Tregs and IL-10. A positive correlation was observed between Tregs, IL-10, and CFA in infected individuals. In contrast, a negative correlation was observed between IFN-γ and IL-10 in both infected and uninfected subjects. Our study reveals that the absence of a sheath antibody and a high level of Tregs and IL-10 are the hallmarks of the persistence of residual filarial infection.


Assuntos
Antígenos de Helmintos/imunologia , Filariose Linfática/imunologia , Interleucina-10/metabolismo , Linfócitos T Reguladores/imunologia , Wuchereria bancrofti/fisiologia , Adulto , Animais , Anticorpos Anti-Helmínticos/sangue , Biomarcadores , Progressão da Doença , Filariose Linfática/diagnóstico , Filariose Linfática/epidemiologia , Feminino , Regulação da Expressão Gênica , Humanos , Índia/epidemiologia , Interferon gama/metabolismo , Interleucina-10/genética , Masculino , Pessoa de Meia-Idade , Doenças Negligenciadas , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...